Mycoplasma pneumoniae extract induces an il-17-associated inflammatory reaction in murine lung: Implication for mycoplasmal pneumonia

Inflammation

Volumn 36, Issue 2, 2013, Pages 285-293

  Kurai, Daisuke ^a   Nakagaki, Kazuhide ^b   Wada, Hiroo ^a   Saraya, Takeshi ^a   Kamiya, Shigeru ^a   Fujioka, Yasunori ^a   Nakata, Koh ^c   Takizawa, Hajime ^a   Goto, Hajime ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

IL 17; IL 23; Mycoplasma pneumoniae; neutrophil

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOPATHOGENESIS; LUNG INJURY; LUNG LAVAGE; LYMPHOCYTE COUNT; MOLECULAR PATHOLOGY; MOUSE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NEUTROPHIL COUNT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; FEMALE; IMMUNIZATION; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED BALB C; MYCOPLASMA PNEUMONIAE; NEUTROPHILS; PNEUMONIA, MYCOPLASMA; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS; MYCOPLASMA PNEUMONIAE;

EID: 84879501526     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9545-3     Document Type: Article

References (29)

1. Waite, K.B.; and D.F. Talkington. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clinical Microbiology Reviews 17: 697-728.
2. Matsuoka, M.; M. Narita, N. Okazaki, H. Ohya, T. Yamazaki, K. Ouchi, I. Suzuki, T. Andoh, T. Kenri, Y. Sasaki, A. Horino, M. Shintani, Y. Arakawa, and T. Sasaki. 2004. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical obtained in Japan. Antimicrobial Agents and Chemotherapy 48: 4624-4630.
3. Opitz, O.; K. Pietsch, S. Ehlers, and E. Jacobs. 1996-1997. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology 196: 575-587.
4. British Thoracic Society Standards of Care Committee. 2002. BTS guidelines for the management of community acquired pneumonia in children. Thorax 57(Supple1): i1-i24.
5. Fernald, G.W.; A.M. Collier, and W.A. Clyde Jr. 1975. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 55: 327-335.
6. Lim, W.S.; S.V. Baudouin, R.C. George, A.T. Hill, C. Jamieson, I. Le Jeune, J.T. Macfarlane, R.C. Read, H.J. Roberts, M.L. Levy, M. Wani, M.A. Woodhead; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. 2009. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3): iii1-55.
7. Steohen, G.B. Mycoplasma pneumoniae and atypical pneumonia In: Mandell, Douglas and Bennett's principle and principles and practice of infectious diseases. G.L. Mandell, J.E. Bennett, R. Dolin, editors. Philadelphia: Elsevier Inc.; 2010: 2481-2489
8. Smith, C.B.; W.T. Friedewald, and R.M. Chanock. 1967. Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. The Journal of the American Medical Association 199: 353-358.
9. Koh, Y.Y.; Y. Park, H.J. Lee, and C.K. Kim. 2001. Levels of interleukin-2, interferon-γ, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 107: E39.
10. Nisar, N.; R. Guleria, S. Kumar, T.C. Chawla, and N.R. Biswas. 2007. Mycoplasma pneumoniae and its role in asthma. Postgraduate Medical Journal 83: 100-104.
11. Lee, K.Y.; H.S. Lee, J.H. Hong, M.H. Lee, J.S. Lee, D. Burgner, and B.C. Lee. 2006. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology 41: 263-268.
12. Radisic, M.; A. Torn, P. Gutierrez, H.A. Defranchi, and P. Pardo. 2000. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clinical Infectious Diseases 31: 1507-1511.
13. Hirao, S.; H. Wada, K. Nakagaki, T. Saraya, D. Kurai, S. Mikura, T. Yasutake, M. Higaki, T. Yokoyama, H. Ishii, K. Nakata, T. Aakashi, S. Kamiya, and H. Goto. 2011. Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. FEMS Immunology and Medical Microbiology 62: 182-189.
14. Saraya, T.; K. Nakata, K. Nakagaki, N. Motoi, K. Iihara, Y. Fujioka, T. Oka, D. Kurai, H. Wada, H. Ishii, H. Taguchi, S. Kamiya, and H. Goto. 2011. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results in Immunology 1: 76-87.
15. Wu, Q.; R.J. Martin, J.G. Rino, R. Breed, R.M. Torres, and H.W. Chu. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes and Infection 9: 78-86.
16. Michelow, I.C.; K. Katz, G.H. McCracken, and R.D. Hardy. 2007. Systemic cytokine profile in children with community-acquired pneumonia. Pediatric Pulmonology 42: 640-645.
17. Pridgeon, C.; L. Bugeon, L. Donnelly, U. Straschil, S.J. Tudhope, P. Fenwick, J.R. Lamb, P.J. Barnes, and M.J. Dallman. 2011. Regulation of IL-17 in chronic inflammation in the human lung. Clinical Science 120: 515-524.
18. Vanaudenaerde, B.M.; S.E. Verleden, R. De, S.I. Vos, A. Vleeschauwer, R. Willems-Widyastuti, D.E.Van Geenens, L.J. Raemdonck, E.K. Dupont, and I.Meyts Verbeken. 2011. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. American Journal of Respiratory and Critical Care Medicine 183: 977-986.
19. Bettelli, E.; T. Korn, M. Oukka, and V.K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057.
20. Mills, K.H. 2008. Induction, function and regulation of IL-17-producing T cells. European Journal of Immunology 38: 2636-2649.
21. Shen, N.; J. Wang, M. Zhao, F. Pei, and B. He. 2011. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Inhal Toxicol 23: 212-218.
22. Chmura, K.; X. Bai, M. Nakamura, P. Kandasamy, M. McGibney, K. Kuronuma, H. Mitsuzawa, D.R. Voelker, and E.D. Chan. 2008. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. American Journal of Physiology - Lung Cellular and Molecular Physiology 295: L220-L230.
23. Sohn, M.H.; K.E. Lee, S.Y. Choi, B.C. Kwon, M.W. Chang, and K.E. Kim. 2005. Effect of Mycoplasma pneumoniae lysate on interleukin-8 gene expression in human respiratory epithelial cells. Chest 128: 322-326.
24. Ferretti, S.; O. Bonneau, G.R. Dubois, C.E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. The Journal of Immunology 170: 2106-2112.
25. Hartupee, J.; C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. The Journal of Immunology 179: 4135-4141.
26. Chu, H.W.; R. Breed, J.G. Rino, R.J. Harbeck, M.R. Sills, and R.J. Martin. 2006. Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background. Microbes and Infection 8: 1764-1772.
27. Fonseca-Aten, M.; A.M. Ríos, A. Mejías, S. Chávez-Bueno, K. Katz, A.M. Gomez, G.H. McCracken Jr.; and R.D. Hardy. 2005. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. American Journal of Physiology - Lung Cellular and Molecular Physiology 32: 201-210.
28. Salvatore, C.M.; M. Fonseca-Aten, K. Katz-Gaynor, A.M. Gomez, A. Mejias, C. Somers, S. Chavez-Bueno, G.H. McCracken, and R.D. Hardy. 2007. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infection and Immunity 75: 236-242.
29. Salvatore, C.M.; M. Fonseca-Aten, K. Katz-Gaynor, A.M. Gomez, and R.D. Hardy. 2008. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia. Infection and Immunity 76: 732-738.